As a co-organiser, IOCB Tech helped facilitate this high-impact event, which surpassed its previous edition in both attendance and the quality of scientific exchange.
The conference served as a vital platform for the growing CEE biotech community to showcase innovation through its competitive pitch session. We would like to extend our congratulations to this year’s winners:
RIANA Therapeutics – focused on novel treatments for acute myeloid leukaemia
HeartBeat.bio AG – developing an advanced drug-discovery platform for heart failure
Nanoflexion – featuring a specialised nanofiber patch for preventing complications in intestinal surgeries.
The success of this year’s conference is a significant milestone as we look toward an even greater challenge. Prague.bio, in coordination with IOCB Tech and international partners BioCentury Inc. and EBD Group, is preparing to host BioEquity Europe in Prague from 4–6 May 2026. This premier event will further solidify the region's position as a systematic and reliable source of European biotech dealflow.